Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Recruiting now · Phase 2
Conditions studied: Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Urothelial Cancer, Biliary Tract Cancer
In brief
TROPION-PanTumor03 will investigate the safety, tolerability, and anti-tumour activity of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Combination with Anticancer Agents in Patients with Advanced/Metastatic Solid Tumours.
Key facts
- Study ID
- NCT05489211
- Run by
- AstraZeneca
- People needed
- 454
- Starts
- 2022-09-06
- Expected to finish
- 2027-10-01
- Last updated by the study team
- 2026-06-17
Who can join
Age: 18 and older, up to 130. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Milan, Italy (enrolling)
- Research Site — Kōtoku, Japan (enrolling)
- Research Site — Hangzhou, China (enrolling)
- Research Site — Suresnes, France (enrolling)
- Research Site — Naples, Italy (enrolling)
- Research Site — Kashiwa, Japan (enrolling)
- Research Site — Los Angeles, California, United States (enrolling)
- Research Site — Guangzhou, China (enrolling)
- Research Site — Zhengzhou, China (enrolling)
- Research Site — Lyon, France (enrolling)
- Research Site — Milan, Italy (enrolling)
- Research Site — Columbus, Ohio, United States (enrolling)
- Research Site — Chūōku, Japan (enrolling)
- Research Site — Nashville, Tennessee, United States (enrolling)
- Research Site — Grand Rapids, Michigan, United States (enrolling)
- Research Site — Houston, Texas, United States (enrolling)
- Research Site — Madison, Wisconsin, United States (enrolling)
- Research Site — East Brunswick, New Jersey, United States (enrolling)
- Research Site — Albuquerque, New Mexico, United States (enrolling)
- Research Site — Shanghai, China (enrolling)
- Research Site — Commack, New York, United States (enrolling)
- Research Site — Bordeaux, France (enrolling)
- Research Site — Cincinnati, Ohio, United States (enrolling)
- Research Site — Santa Rosa, California, United States (enrolling)
- Research Site — Nagoya, Japan (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.